Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
77.15 USD | +0.99% |
|
+1.75% | -2.84% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.84% | 3.63B | |
+1.87% | 93.91B | |
-1.32% | 38.4B | |
-12.70% | 32.61B | |
+74.71% | 28.2B | |
-12.23% | 15.91B | |
+1.80% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Axsome Therapeutics, Inc. Appoints John Golubieski as Chief Financial Officer, Effective August 4, 2017